Medical Communications

Showing 15 posts of 6411 posts found.

ai_robot

AI, big data: Making a case for faster drug discovery

October 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Big Data, feature, healthcare, research

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI …
novo_flag

Novo Nordisk’s Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients

October 12, 2018 Medical Communications, Research and Development Fiasp, Novo Nordisk, Type 1 diabetes, diabetes, pharma

New data unveiled by Novo Nordisk has shown that its insulin injection Fiasp (fast-acting insulin aspart) could provide a better …
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, biosimilars. GSK, manufacturing, pharma, top 10

Politics played a big role in pharma this week after Trump introduced legislation aimed at reducing the price of drugs. …
trvn1

Trevena’s opioid injection fails to win over FDA committee

October 12, 2018 Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma

Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …

Chanelle Pharma announces €86m investment over next five years

October 12, 2018 Medical Communications Ireland, chanelle, generics, investment, research

Chanelle Pharmaceuticals, one of the largest Irish-owned pharmaceutical companies in Ireland, have announced an €86 million investment programme over the …

USA struggles and middle income countries could do more in tackling health inequality according to Oxfam report

October 12, 2018 Medical Communications Latin America, USA, health, inequality, oxfam

A cluster of Latin American countries such as Costa Rica, Uruguay and Argentina, and a cluster of OECD countries with …

Living with Langerhans Cell Histiocytosis

October 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Langerhans Cell Histiocytosis, feature. pharma, patient experience, rare diseae

Affected as a young child by a rare disease which targets just one in 200,000 and led to neurodegeneration throughout …
martin_van_trieste

Non-profit generic drug company Civica Rx appoints former Amgen quality chief as new CEO

October 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbot, Amgen, Bayer, civica rx, generic drugs, hospitals

Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen …
capture

The economics of mental health

October 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, health economics and outcomes research, mental health, pharma

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done …
gsk_boronia_australia

GSK to cut almost 200 jobs at UK site

October 5, 2018 Manufacturing and Production, Medical Communications GSK, UK, Ulverston, job cuts, pharma

GlaxoSmithKline has announced that it is to slash half of its workforce at its site in Ulverston, UK, as part …
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10

As September came to a close and October began the UK was hit hard in the headlines after American firm …
roche_dark_0

FDA expands indication of Roche’s Hemlibra in haemophilia

October 5, 2018 Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma

The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …
gilead_hq_at_stockley_park_london_2

NHS England appoves Gilead’s CAR T therapy Yescarta

October 5, 2018 Medical Communications Gilead, NHS, NICE, UK, Yescarta

Gilead’s CAR T therapy Yescarta is set to be made available on the NHS in England for adults with aggressive …
european_commission_web_5

MHRA to consult on potential for no-deal Brexit

October 5, 2018 Medical Communications EU, MHRA, brexit, uk politics

The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …
ianread

Ian Read steps down as Pfizer CEO

October 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Ian Read, Pfizer, pharma

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
The Gateway to Local Adoption Series

Latest content